Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
US10028964B2 · kind B2 · utility
2Cited by
4References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 23, 2013 |
| Grant date | Jul 24, 2018 |
| Priority date | — |
| Expiry date | Jun 23, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a dry powder formulation comprising corticosteroid and a beta2-adrenergic drug in combination, its process preparation, and therapeutic uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.